Mirxes Holding Co Ltd

02629

Company Profile

  • Business description

    Mirxes Holding Co Ltd is a miRNA technology company that is making diagnostic solutions for the screening of diseases accessible across its key markets in Asia, including Singapore and China. It has one Core Product (namely, GASTROClearTM), two other commercialized products (namely, LUNGClearTM and FortitudeTM), and six product candidates at the pre-clinical stage, as illustrated in the chart below. GASTROClearTM, its Core Product, is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. The company generates the majority of its revenue from Singapore.

  • Contact

    2 Tukang Innovation Grove
    No. 09-02 JTC MedTech Hub
    Singapore618305
    SGP

    T: +65 68162931

    https://www.mirxes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    352

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,766.0075.100.86%
CAC 407,763.8426.640.34%
DAX 4024,091.62160.950.67%
Dow JONES (US)42,519.64214.160.51%
FTSE 1008,787.0212.760.15%
HKSE23,680.73168.240.72%
NASDAQ19,398.96156.340.81%
Nikkei 22537,775.04328.230.88%
NZX 50 Index12,479.28152.051.23%
S&P 5005,970.3734.430.58%
S&P/ASX 2008,539.3072.600.86%
SSE Composite Index3,376.5814.610.43%

Market Movers